SEARCH

SEARCH BY CITATION

References

  • Andersson M., Elmberger P. G., Edlund C., Kristensson K. and Dallner G. (1990) Rates of cholesterol, ubiquinone, dolichol and dolichyl-P biosynthesis in rat brain slices. FEBS Lett. 269, 1518.
  • Antonny B. (2004) SNARE filtering by dynamin. Cell 119, 581582.
  • Bamberger M. E., Harris M. E., McDonald D. R., Husemann J. and Landreth G. E. (2003) A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation. J. Neurosci. 23, 26652674.
  • Bonifacino J. S. and Traub L. M. (2003) Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu. Rev. Biochem. 72, 395447.
  • Brown D. A. and Rose J. K. (1992) Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68, 533544.
  • Buxbaum J. D., Cullen E. I. and Friedhoff L. T. (2002) Pharmacological concentrations of the HMG-CoA reductase inhibitor lovastatin decrease the formation of the Alzheimer beta-amyloid peptide in vitro and in patients. Front Biosci. 7, a50a59.
  • Cataldo A. M., Petanceska S., Terio N. B., Peterhoff C. M., Durham R., Mercken M., Mehta P. D., Buxbaum J., Haroutunian V. and Nixon R. A. (2004) Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome. Neurobiol. Aging 25, 12631272.
  • Chauhan N. B. (2003) Membrane dynamics, cholesterol homeostasis, and Alzheimer’s disease. J. Lipid Res. 44, 20192029.
  • Chintagari N. R., Jin N., Wang P., Narasaraju T. A., Chen J. and Liu L. (2006) Effect of cholesterol depletion on exocytosis of alveolar type II cells. Am. J. Respir. Cell Mol. Biol. 34, 677687.
  • Daukas G. and Zigmond S. H. (1985) Inhibition of receptor-mediated but not fluid-phase endocytosis in polymorphonuclear leukocytes. J. Cell Biol. 101, 16731679.
  • Echarri A. and Del Pozo M. A. (2006) Caveolae internalization regulates integrin-dependent signaling pathways. Cell Cycle 5, 21792182.
  • Ehehalt R., Keller P., Haass C., Thiele C. and Simons K. (2003) Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J. Cell Biol. 160, 113123.
  • Fassbender K., Simons M., Bergmann C. et al. (2001) Simvastatin strongly reduces levels of Alzheimer’s disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc. Natl Acad. Sci. USA 98, 58565861.
  • Garcia-Marcos M., Tandel S., Pochet S., Genin J., De Lorenzi M., Gomez F., Kumps A., Marino A. and Dehaye J. P. (2005) Cholesterol depletion perturbs calcium handling by rat submandibular glands. J. Cell. Physiol. 203, 429438.
  • Gaus K., Rodriguez M., Ruberu K. R., Gelissen I., Sloane T. M., Kritharides L. and Jessup W. (2005) Domain-specific lipid distribution in macrophage plasma membranes. J. Lipid Res. 46, 15261538.
  • Grbovic O. M., Mathews P. M., Jiang Y., Schmidt S. D., Dinakar R., Summers-Terio N. B., Ceresa B. P., Nixon R. A. and Cataldo A. M. (2003) Rab5-stimulated up-regulation of the endocytic pathway increases intracellular beta-cleaved amyloid precursor protein carboxyl-terminal fragment levels and Abeta production. J. Biol. Chem. 278, 3126131268.
  • Green R. C., McNagny S. E., Jayakumar P., Cupples L. A. and Farrer L. A. (2006) Statin use and the risk of Alzheimer’s disease: the MIRAGE Study. Alzheimer Dement 2, 96103.
  • Gupta A. and Pansari K. (2003) Inflammation and Alzheimer’s disease. Int. J. Clin. Pract. 57, 3639.
  • Halliday G., Robinson S. R., Shepherd C. and Kril J. (2000) Alzheimer’s disease and inflammation: a review of cellular and therapeutic mechanisms. Clin. Exp. Pharmacol. Physiol. 27, 18.
  • Jick H., Zornberg G. L., Jick S. S., Seshadri S. and Drachman D. A. (2000) Statins and the risk of dementia. Lancet 356, 16271631.
  • Kang J., Lemaire H. G., Unterbeck A., Salbaum J. M., Masters C. L., Grzeschik K. H., Multhaup G., Beyreuther K. and Muller-Hill B. (1987) The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733736.
  • Khan M., Contreras M. and Singh I. (2000) Endotoxin-induced alterations of lipid and fatty acid compositions in rat liver peroxisomes. J. Endotoxin. Res. 6, 4150.
  • Kojro E., Gimpl G., Lammich S., Marz W. and Fahrenholz F. (2001) Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10. Proc. Natl Acad. Sci. USA 98, 58155820.
  • Koo E. H. and Squazzo S. L. (1994) Evidence that production and release of amyloid beta-protein involves the endocytic pathway. J. Biol. Chem. 269, 1738617389.
  • Ledoux S., Laouari D., Essig M., Runembert I., Trugnan G., Michel J. B. and Friedlander G. (2002) Lovastatin enhances ecto-5′-nucleotidase activity and cell surface expression in endothelial cells: implication of rho-family GTPases. Circ. Res. 90, 420427.
  • Lutjohann D., Stroick M., Bertsch T., Kuhl S., Lindenthal B., Thelen K., Andersson U., Bjorkhem I., Bergmann Kv K. and Fassbender K. (2004) High doses of simvastatin, pravastatin, and cholesterol reduce brain cholesterol synthesis in guinea pigs. Steroids 69, 431438.
  • Madore N., Smith K. L., Graham C. H., Jen A., Brady K., Hall S. and Morris R. (1999) Functionally different GPI proteins are organized in different domains on the neuronal surface. EMBO J. 18, 69176926.
  • Marquez-Sterling N. R., Lo A. C., Sisodia S. S. and Koo E. H. (1997) Trafficking of cell-surface beta-amyloid precursor protein: evidence that a sorting intermediate participates in synaptic vesicle recycling. J. Neurosci. 17, 140151.
  • McGeer E. G. and McGeer P. L. (2003) Inflammatory processes in Alzheimer’s disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 27, 741749.
  • Meske V., Albert F., Richter D., Schwarze J. and Ohm T. G. (2003) Blockade of HMG-CoA reductase activity causes changes in microtubule-stabilizing protein tau via suppression of geranylgeranylpyrophosphate formation: implications for Alzheimer’s disease. Eur. J. Neurosci. 17, 93102.
  • Mills I. G., Jones A. T. and Clague M. J. (1999) Regulation of endosome fusion. Mol. Membr. Biol. 16, 7379.
  • Nichols B. (2003) Caveosomes and endocytosis of lipid rafts. J. Cell Sci. 116, 47074714.
  • Ostrowski S. M., Wilkinson B. L., Golde T. E. and Landreth G. (2007) Statins reduce amyloid-beta production through inhibition of protein isoprenylation. J. Biol. Chem. 282, 2683226844.
  • Pappolla M. A., Bryant-Thomas T. K., Herbert D. et al. (2003) Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology. Neurology 61, 199205.
  • Parvathy S., Ehrlich M., Pedrini S., Diaz N., Refolo L., Buxbaum J. D., Bogush A., Petanceska S. and Gandy S. (2004) Atorvastatin-induced activation of Alzheimer’s alpha secretase is resistant to standard inhibitors of protein phosphorylation-regulated ectodomain shedding. J. Neurochem. 90, 10051010.
  • Pedrini S., Carter T. L., Prendergast G., Petanceska S., Ehrlich M. E. and Gandy S. (2005) Modulation of statin-activated shedding of Alzheimer APP ectodomain by ROCK. PLoS Med 2, e18.
  • Pelkmans L., Burli T., Zerial M. and Helenius A. (2004) Caveolin-stabilized membrane domains as multifunctional transport and sorting devices in endocytic membrane traffic. Cell 118, 767780.
  • Pralle A., Keller P., Florin E. L., Simons K. and Horber J. K. (2000) Sphingolipid-cholesterol rafts diffuse as small entities in the plasma membrane of mammalian cells. J. Cell Biol. 148, 9971008.
  • Refolo L. M., Sambamurti K., Efthimiopoulos S., Pappolla M. A. and Robakis N. K. (1995) Evidence that secretase cleavage of cell surface Alzheimer amyloid precursor occurs after normal endocytic internalization. J. Neurosci. Res. 40, 694706.
  • Refolo L. M., Malester B., LaFrancois J., Bryant-Thomas T., Wang R., Tint G. S., Sambamurti K., Duff K. and Pappolla M. A. (2000) Hypercholesterolemia accelerates the Alzheimer’s amyloid pathology in a transgenic mouse model. Neurobiol. Dis. 7, 321331.
  • Riddell D. R., Christie G., Hussain I. and Dingwall C. (2001) Compartmentalization of beta-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts. Curr. Biol. 11, 12881293.
  • Roheim P. S., Carey M., Forte T. and Vega G. L. (1979) Apolipoproteins in human cerebrospinal fluid. Proc. Natl Acad. Sci. USA 76, 46464649.
  • Roper K., Corbeil D. and Huttner W. B. (2000) Retention of prominin in microvilli reveals distinct cholesterol-based lipid micro-domains in the apical plasma membrane. Nat. Cell Biol 2, 582592.
  • Rouvinski A., Gahali-Sass I., Stav I., Metzer E., Atlan H. and Taraboulos A. (2003) Both raft- and non-raft proteins associate with CHAPS-insoluble complexes: some APP in large complexes. Biochem. Biophys. Res. Commun. 308, 750758.
  • Rybin V., Ullrich O., Rubino M., Alexandrov K., Simon I., Seabra M. C., Goody R. and Zerial M. (1996) GTPase activity of Rab5 acts as a timer for endocytic membrane fusion. Nature 383, 266269.
  • Sambamurti K., Sevlever D., Koothan T. et al. (1999) Glycosylphosphatidylinositol-anchored proteins play an important role in the biogenesis of the Alzheimer’s amyloid beta-protein. J. Biol. Chem. 274, 2681026814.
  • Serougne-Gautheron C. and Chevallier F. (1973) Time course of biosynthetic cholesterol in the adult rat brain. Biochim. Biophys. Acta 316, 244250.
  • Shie F. S., Jin L. W., Cook D. G., Leverenz J. B. and LeBoeuf R. C. (2002) Diet-induced hypercholesterolemia enhances brain A beta accumulation in transgenic mice. Neuroreport 13, 455459.
  • Sidaway J. E., Davidson R. G., McTaggart F., Orton T. C., Scott R. C., Smith G. J. and Brunskill N. J. (2004) Inhibitors of 3-hydroxy-3-methylglutaryl-CoA reductase reduce receptor-mediated endocytosis in opossum kidney cells. J. Am. Soc. Nephrol. 15, 22582265.
  • Simons K. and Toomre D. (2000) Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1, 3139.
  • Simons M., Keller P., De Strooper B., Beyreuther K., Dotti C. G. and Simons K. (1998) Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc. Natl Acad. Sci. USA 95, 64606464.
  • Simons M., Keller P., Dichgans J. and Schulz J. B. (2001) Cholesterol and Alzheimer’s disease: is there a link? Neurology 57, 10891093.
  • Sinha S., Anderson J. P., Barbour R. et al. (1999) Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature 402, 537540.
  • Soriano S., Chyung A. S., Chen X., Stokin G. B., Lee V. M. and Koo E. H. (1999) Expression of beta-amyloid precursor protein-CD3γ chimeras to demonstrate the selective generation of amyloid beta(1-40) and amyloid beta(1-42) peptides within secretory and endocytic compartments. J. Biol. Chem. 274, 3229532300.
  • Symons M. and Rusk N. (2003) Control of vesicular trafficking by Rho GTPases. Curr. Biol. 13, R409R418.
  • Tong X. K., Hussain N. K., Adams A. G., O’Bryan J. P. and McPherson P. S. (2000) Intersection can regulate the Ras/MAP kinase pathway independent of its role in endocytosis. J. Biol. Chem. 275, 2989429899.
  • Verhulst A., D’Haese P. C. and De Broe M. E. (2004) Inhibitors of HMG-CoA reductase reduce receptor-mediated endocytosis in human kidney proximal tubular cells. J. Am. Soc. Nephrol. 15, 22492257.
  • Vetrivel K. S., Cheng H., Lin W., Sakurai T., Li T., Nukina N., Wong P. C., Xu H. and Thinakaran G. (2004) Association of gamma-secretase with lipid rafts in post-Golgi and endosome membranes. J. Biol. Chem. 279, 4494544954.
  • Vetrivel K. S., Cheng H., Kim S. H., Chen Y., Barnes N. Y., Parent A. T., Sisodia S. S. and Thinakaran G. (2005) Spatial segregation of gamma-secretase and substrates in distinct membrane domains. J. Biol. Chem. 280, 2589225900.
  • Walter J., Fluhrer R., Hartung B., Willem M., Kaether C., Capell A., Lammich S., Multhaup G. and Haass C. (2001) Phosphorylation regulates intracellular trafficking of beta-secretase. J. Biol. Chem. 276, 1463414641.
  • Wolozin B. (2001) A fluid connection: cholesterol and Aβ. Proc. Natl Acad. Sci. USA 98, 53715373.
  • Wolozin B., Kellman W., Ruosseau P., Celesia G. G. and Siegel G. (2000) Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch. Neurol. 57, 14391443.
  • Won J. S., Im Y. B., Key L., Singh I. and Singh A. K. (2003) The involvement of glucose metabolism in the regulation of inducible nitric oxide synthase gene expression in glial cells: possible role of glucose-6-phosphate dehydrogenase and CCAAT/enhancing binding protein. J. Neurosci. 23, 74707478.
  • Woodman P. G. (2000) Biogenesis of the sorting endosome: the role of Rab5. Traffic 1, 695701.
  • Zeng Y., Tao N., Chung K. N., Heuser J. E. and Lublin D. M. (2003) Endocytosis of oxidized low density lipoprotein through scavenger receptor CD36 utilizes a lipid raft pathway that does not require caveolin-1. J. Biol. Chem. 278, 4593145936.
  • Zerial M. and McBride H. (2001) Rab proteins as membrane organizers. Nat. Rev. Mol. Cell Biol. 2, 107117.